Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Other 1Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 9Lymphoma 9Hodgkin Disease 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 7Leukemia, Myeloid, Acute 6Multiple Myeloma 5Lymphoma, Large B-Cell, Diffuse 5Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Burkitt Lymphoma 3Blast Crisis 3Stomatitis 2Recurrence 2Neoplasms, Plasma Cell 2Lymphoma, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Sezary Syndrome 1Radiation Injuries 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1

Interventions

Fibroblast Growth Factor 7 2Zinc Sulfate 1Zinc 1Whole-Body Irradiation 1Saline Solution 1Mannitol 1Laser Therapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomatitis × Fibroblast Growth Factor 7 × Lymphoid × Clear all
NCT00460421 2014-12-05

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

Swedish Orphan Biovitrum

Phase 1 Completed
27 enrolled 19 charts
LymphoidOther hematologic neoplasm

Leukemia, Stomatitis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00352703 2014-11-03

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Swedish Orphan Biovitrum

Phase 4 Completed
145 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡